From: Malignant pertussis in infants: factors associated with mortality in a multicenter cohort study
Non-survivors (n = 9) | Survivors (n = 14) | p | All patients (n = 23) | |
---|---|---|---|---|
Cardiovascular failure, n (%) | 9 (100) | 5 (36) | 0.003 | 14 (61) |
Pulmonary hypertension, n (%) | 9 (100) | 4 (29) | 0.002 | 13 (56) |
Kidney failure, n (%) | 8 (89) | 3 (21) | 0.003 | 11 (48) |
Anuria, n (%) | 9 (100) | 3 (21) | < 0.001 | 12 (52) |
Neurological failure, n (%) | 3 (33) | 6 (43) | 1 | 9 (39) |
Liver failure, n (%) | 5 (56) | 2 (14) | 0.049 | 7 (30) |
Documented bacterial superinfection, n (%)a | 6 (67) | 8 (57) | 1 | 14 (61) |
Documented viral co-infection, n (%)b | 4 (44) | 5 (36) | 1 | 9 (39) |
Hematological failure, n (%) | 5 (56) | 2 (14) | 0.02 | 7 (30) |
Secondary thrombopenia, n (%) | 7 (78) | 6 (43) | 0.19 | 13 (57) |
Minimal sodium level, mmol/l, median [IQR] | 122 [119–125] | 131 [129–135] | 0.003 | 130 [122–135] |
Maximal lactate, mmol/l, median [IQR] | 9 [3–16] | 3 [2–4] | 0.02 | 3 [2–9] |
Minimal pH, median [IQR] | 7.05 [6.8–7.1] | 7.24 [7.17–7.32] | 0.002 | 7.18 [7.05–7.26] |
Maximal pCO2, kPa, median [IQR] | 9.1 [8.7–12.3] | 8.3 [7.0–11.0] | 0.25 | 9.0 [7.7–11.5] |
Maximal creatinine, µmol/l, median [IQR] | 81 [49–110] | 27 [23–51] | 0.002 | 40 [25–82] |
Maximal C-reactive protein, mg/l, median [IQR] | 203 [135–237] | 90 [7–205] | 0.11 | 135 [30–217] |
Maximal procalcitonin, µg/l, median [IQR] | 19.0 [6.3–23.7] | 1.0 [0.2–4.3] | 0.012 | 3.3 [0.5–19.3] |
WBC growth, G/l/day, median [IQR] | 21 [10–28] | 6 [3–7] | 0.007 | 6 [3–17] |
Maximal WBC count, G/l, median [IQR] | 88 [63–95] | 65 [53–81] | 0.12 | 71 [56–91] |
Maximal neutrophils, G/l, median [IQR] | 41 [23–47] | 25 [16–37] | 0.14 | 26 [18–46] |
Maximal lymphocytes, G/l, median [IQR] | 33 [26–34] | 33 [28–39] | 0.83 | 32 [28–37] |
Lymphocyte/neutrophil ratio < 1, n (%) | 8 (89) | 3 (21) | 0.003 | 12 (52) |